Announcements

September 1, 2022

Genetics Signatures (ASX:GSS) – Appendix 4E – Preliminary Final Report

View Announcement

July 27, 2022

Genetics Signatures (ASX:GSS) – Quarterly update and Appendix 4C

View Announcement

July 26, 2022

Genetic Signatures (ASX:GSS) – Clinical Trial Recruitment Completed for US Enteric Kit

View Announcement

May 13, 2022

Genetic Signatures (ASX:GSS) – Appointment of Non-Executive Director, Caroline Waldron

View Announcement

March 31, 2022

Quarterly Activities Report and Appendix 4C

View Announcement

March 30, 2022

Genetic Signatures (ASX.GSS) – Public Health Wales

View Announcement

February 18, 2022

18 February 2022- GSS Half Yearly Report

View Announcement

February 17, 2022

Genetic Signatures (ASX.GSS) – Investor Webinar Presentation

View Announcement

January 10, 2022

Genetic Signatures (ASX:GSS) – Saliva-Based Protocol for SARS-CoV-2

December 21, 2021

Genetic Signatures (ASX:GSS) – Investor Update